candisil hct 8 mg/12,5 mg tabletes
laboratorios liconsa, s.a., spain - candesartanum cilexetilum, hydrochlorothiazidum - tablete - 8 mg/12,5 mg
candisil hct 32 mg/25 mg tabletes
laboratorios liconsa, s.a., spain - candesartanum cilexetilum, hydrochlorothiazidum - tablete - 32 mg/25 mg
ertapenem qilu 1 g pulveris infūziju šķīduma koncentrāta pagatavošanai
qilu pharma spain s.l., spain - ertapenēms - pulveris infūziju šķīduma koncentrāta pagatavošanai - 1 g
kestine 20 mg apvalkotās tabletes
almirall, s.a., spain - ebastīns - apvalkotā tablete - 20 mg
kestine 10 mg apvalkotās tabletes
almirall, s.a., spain - ebastīns - apvalkotā tablete - 10 mg
kestine 10 mg apvalkotās tabletes
almirall, s.a., spain - ebastīns - apvalkotā tablete - 10 mg
meropenem qilu 1 g pulveris injekciju/infūziju šķīduma pagatavošanai
qilu pharma spain s.l., spain - meropenēms - pulveris injekciju/infūziju šķīduma pagatavošanai - 1 g
valsol plus 160 mg/25 mg apvalkotās tabletes
laboratorios liconsa, s.a., spain - valsartanum, hydrochlorothiazidum - apvalkotā tablete - 160 mg/25 mg
valsol plus 80 mg/12,5 mg apvalkotās tabletes
laboratorios liconsa, s.a., spain - valsartanum, hydrochlorothiazidum - apvalkotā tablete - 80 mg/12,5 mg
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcīnas - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.